Blood Culture Test Market is Projected to Reach at a CAGR of 8.0% | Key Players: bioMérieux, IRIDICA, Bruker
The overall market of blood culture test is projected to reach $4,768.9 million by 2021 from $3,252.6 million in 2016, at a CAGR of 8.0%.
Factors such as rapidly rising aging population, increase in product approvals and launches, high incidence of bloodstream infections, high prevalence of infectious diseases, and increase in demand for rapid diagnostic techniques are driving the growth of the blood culture test market during the forecast period.
Geographically, the market of blood culture test is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the blood culture test market. However, the Asian market is expected to grow at the highest CAGR. Growth in the Asian market can be attributed to the high incidence of sepsis and government initiatives to increase awareness on the disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region.
To know about the assumptions considered for the study, download the pdf brochure @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159606753
The blood culture test market is highly competitive, with prominent players such as Becton, Dickinson and Company (U.S.), bioMérieux SA (France), and Thermo Fisher Scientific, Inc. (U.S.). Some of the other players in this market include Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), IRIDICA (U.S.), Beckman Coulter (U.S.), Corporation (U.S.), and T2 Biosystems (U.S.).
Target Audience
- Molecular Diagnostic Companies
- Manufacturers of Clinical Microbiology Instruments and Consumables
- Venture Capitalists
- Research and Consulting Firms
- Clinical Diagnostic Laboratories
With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.
The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
- Product matrix, which gives a detailed comparison of the product portfolios of the top companies
- Further breakdown of the Rest of the World market into Pacific Countries, LATAM, and Middle East and Africa
Growth of the market can be attributed to increasing number of sepsis cases and high cost of treatment, rising geriatric population, growing number of product approvals, high incidence of bloodstream infections, growth in demand for rapid diagnostic techniques, and high prevalence of infectious diseases are driving the market growth of blood culture test. On the other hand, factors such as high cost of automated instruments and lack of skilled laboratory technicians are limiting the market growth of blood culture test.
High incidence of blood stream infections are expected to drive the market growth to a certain extent during the forecast period.
Research Methodology
This study estimates the market size of blood culture test for 2016 and projects its demand till 2021. Top-down and bottom-up approaches were used to estimate and validate the sizes of the global market and various other dependent submarkets of the market.
The key players in the market were identified through secondary research, and their market contributions in the respective regions determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined by secondary sources and verified through primary sources.
Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=159606753
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment